Центр научного сотрудничества "Интерактив плюс"
info@interactive-plus.ru
+7 (8352) 222-490
2130122532
Центр научного сотрудничества «Интерактив плюс»
RU
428000
Чувашская Республика
г.Чебоксары
ул.Гражданская, д.75
428000, Россия, Чувашская Республика, г. Чебоксары, улица Гражданская, дом 75
+7 (8352) 222-490
RU
428000
Чувашская Республика
г.Чебоксары
ул.Гражданская, д.75
56.125001
47.208966

The regulation of expression of the hormone leptin

Research Article
DOI: 10.21661/r-116212
Open Access
Monthly international scientific journal «Interactive science»
Creative commons logo
Published in:
Monthly international scientific journal «Interactive science»
Author:
Baranov S.N. 1
Scientific adviser:
Kiseleva M.M.1
Work direction:
Медицина
Rating:
Article accesses:
3020
Published in:
doaj
eLibrary.ru
1 FSFEI of HE “Kurgan State University”
For citation:

  • Metadata
  • Full text
  • Metrics
UDC 612

Abstract

This article discusses some ways of the process expression and its regulation of peptide hormone leptin, which performs the function of the endocrine mediator with the multi-action.

References

  1. 1. Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению // Русский медицинский журнал. – 2001. – №9 (2). – С. 56–76.
  2. 2. Ahima R.S., Saper C.B., Flier J.S., Elmquist J.K. Leptin regulation of neuroendocrine systems // Front. Neuroendocrinol. – 2000; 21: 263–307.
  3. 3. Ankarberg-Lindgren C., Dahlgren J., Carlsson B. et al. Clinical Study: Leptin levels show diurnal variation throughout puberty in healthy children, and follow a gender-specific pattern // European Journal of Endocrinology Eur J Endocrinol. – 2001 Jul; 145(1): 43–51.
  4. 4. Bray G.A. Etiology and pathogenesis of obesity // Clin Cornerstone. – 1999; 2 (3): 1–15.
  5. 5. Bray G.A. The underlying basis for obesity: relationship to cancer // J Nutr. – 2002 Nov; 132(11): 3451–5.
  6. 6. Campfield L.A., Smith F.J., Guisez Y. et al. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks // Science. – 1995; 269: 546–549.
  7. 7. Diamond F.B. Jr., Eichler D.C. Leptin and the adipocyte endocrine system // Crit Rev Clin Lab Sci. – 2002 Sep; 39(4–5): 499–525.
  8. 8. Elmquist J.K. Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin // Physiol Behav. – 2001 Nov-Dec; 74(4–5): 703–8.
  9. 9. Flier J.S. Obesity and the hypothalamus: novel peptides for new pathways. – 1998, 92: 437440.
  10. 10. Hu X., Juneja S. C., Maihle N. J. et al. Leptin – a growth factor in normal and malignant breast cells and for normal mammary gland development // J Natl Cancer Inst. – 2002 Nov 20; 94(22): 1704–1711.
  11. 11. Juge-Aubry C. E., Meier C. A. Immunomodulatory actions of leptin // Molecular and Cellular Endocrinology. – 2002; 194: 1–7.
  12. 12. Savino F., Costamagna M., Prino A et al. Leptin levels in breast-fed and formula-fed infants // Acta Paediatr. – 2002; 91(9): 897–902.
  13. 13. Van Gaal L.F., Wauters M.A., Mertens I.L. et al. Clinical endocrinology of human leptin // Int J Obes Relat Metab Disord. – 1999 Feb; 23 Suppl 1: 29–36.
  14. 14. Wauters M., Considine R.V., van Gaal L.F. Human leptin: from an adipocyte hormone to an endocrine mediator // Eur. J. Endocrinol. – 2000; 143, 293–311

Comments(0)

When adding a comment stipulate:
  • the relevance of the published material;
  • general estimation (originality and relevance of the topic, completeness, depth, comprehensiveness of topic disclosure, consistency, coherence, evidence, structural ordering, nature and the accuracy of the examples, illustrative material, the credibility of the conclusions;
  • disadvantages, shortcomings;
  • questions and wishes to author.